MabDesign Watchs

Take a look at last editions of Immunowatch

MabDesign’s Immunowatch is a one-of-a-kind information monitoring newsletter in the field of biotherapy. Its aim is to provide our network with the most recent and pertinent data gathered or generated through the key expertise of MabDesign and its collaborators in scientific research, business intelligence, market analysis and intellectual property. Each edition will focus on one trending type of biotherapy and its content will be decided by an editorial composed of two field experts, one from academia and one from the industry.

For any query on this newsletter, please contact us at



Download “Monoclonal Antibodies” edition






Download “COVID-19” special edition (may 2020)

Download first update ( 29/05/2020)

Download second update (19/06/2020)

Download third update (07/09/2020)

Download fourth update (14/12/2020)

Download fifth update (05/03/2021)

Download sixth update (16/02/2021)


Download “CAR-T cells ” edition







Download “Bioproduction” edition







Immunowatch Gene therapy

Download “Gene Therapy” edition








Download “Cell Therapy” edition

Take a look at the new

2022 marks the lauch of MabDesign’s new information-monitoring letter in the field of bioprocessing.

To start in style, the No.1 edition is a special one dedicated entirely to our 2021 Bioproduction Congress and its highlights. In this special edition of BioprocessWatch, you will find the summary of the different keynote lectures, the talks of all the parallel sessions including the innovation sessions, presentation of the workshops and one article on the roundtable discussions which took place from the 30th of September to the 1st of October 2021 in Lyon.

We would like to thank all the sponsors, speakers and participants who have contributed in making the 2021 Bioproduction Congress a success.


BioprocessWatch édition spéciale

Download special edition BioprocessWatch



Latest news:

We are currently working on a classic edition of BioprocessWatch that will focus on antibody production to be released later this year. Should you wish to make a contribution or book an advert please contact

This is a unique website which will require a more modern browser to work!

Please upgrade today!